Results 71 to 80 of about 1,999,014 (306)

Survival COVID-19 in Adult Patients with Liver Cirrhosis

open access: yesThe Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy, 2021
Background: COVID-19 is a disease caused by infection of SARS-CoV-2 virus which leads to mortality due to respiratory failure. The progression of COVID-19 is more severe in patients with pre-existence morbidities, including liver disease. Recently, a few
Gita Aprilicia   +9 more
doaj   +1 more source

Liver cirrhosis-epidemiological and Clinical Aspects [PDF]

open access: yes, 2008
Liver cirrhosis is the end-stage of many different chronic liver diseases. Limited data exists on the epidemiology, natural history and complications of liver cirrhosis such as esophageal varices and malignancies in the Nordic countries after the ...
Gunnarsdóttir, Steingerður Anna
core  

Role of Oxygen Free Radicals, Nitric Oxide and Mitochondria in Mediating Cardiac Alterations During Liver Cirrhosis Induced by Thioacetamide [PDF]

open access: yes, 2016
Thioacetamide (TAA) administration is widely used for induction of liver cirrhosis in rats, where reactive oxygen radicals (ROS) and nitric oxide (NO) participate in development of liver damage.
Amirtharaj, G. Jayakumar   +5 more
core   +2 more sources

Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment

open access: yesCancer Medicine, 2019
It is well known that the incidence of developing hepatocelluler carcinoma (HCC) is increased in liver cirrhosis of different etiologies. However, comparison of HCC incidence in various liver diseases has not yet been estimated.
K. Tarao   +7 more
semanticscholar   +1 more source

Systematic review on the reporting quality of randomized controlled trials in patients with hepatitis B or C in China

open access: yesInternational Journal of Infectious Diseases, 2018
Background: The numbers of articles reporting randomized controlled trials (RCTs) on viral hepatitis in China have been increasing, but there have been few systematic studies evaluating the reporting quality of RCTs in this field.
Na Zeng   +7 more
doaj   +1 more source

Liver Cirrhosis: Pathophysiology, Diagnosis, and Management [PDF]

open access: yes, 2023
Liver disease is still a concern in world health and liver cirrhosis is the eleventh leading cause of death in the world. Cirrhosis caused 1.32 million deaths in 2017. Liver cirrhosis is a fibrosis or nodule formation in the liver.
Hendriani, Aulia Dwi   +2 more
core   +1 more source

Liver cirrhosis and pregnancy

open access: yesAnnals of Hepatology, 2006
The liver accomplishes multiple functions such as the biotransformation of insoluble compounds (drugs, toxins, bilirubin), the metabolism and excretion of lipids (cholesterol in particular) the production of several plasma proteins (good examples are albumin, coagulation factors, transferrin), and the metabolism of amino acids and carbohydrates.
Claudio Tiribelli, Igino Rigato
openaire   +5 more sources

The burden of clostridium difficile infection in patients with liver cirrhosis [PDF]

open access: yes, 2019
Clostridium Difficile Infection (CDI) has registered a dramatically increasing incidence in the general population over the past decades. Nowadays, Clostridium Difficile is the leading cause of hospital-acquired diarrhea in Europe and North America ...
Dumitru, Andrada   +5 more
core   +1 more source

Telomere shortening as genetic risk factor of liver cirrhosis [PDF]

open access: yes, 2015
Cirrhosis is the main complication of chronic liver disease, leads to progressive liver function impairment and is the main risk factor for the development of liver cancer.
Carulli, Lucia
core   +1 more source

Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes

open access: yesHepatology, 2016
Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide. We estimated the global prevalence, incidence, progression, and outcomes of NAFLD and nonalcoholic steatohepatitis (NASH).
Z. Younossi   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy